A longitudinal study of the competitive positions and entry paths of European firms in the U.S. pharmaceutical market

Article Abstract:

The market entry and development choices and strategies of European companies that broke into the US pharmaceutical market between 1969 and 1988 are examined. The study also investigates the resulting industry dynamics and the strategic positions assumed by individual companies while the market develops. The entry paths taken by the European pharmaceutical firms are studied through dynamic strategic group analysis, while a series of strategic group maps are employed to compare the companies' competitive positions in the US with those of the American firms that were first in the market. The study tests four hypotheses addressing initial entry point, incremental market development, eventual alignment based on parental sources, and patterns of response. The results are discussed.

Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, United States, Europe, Pharmaceutical industry, Drugs, Market share, Corporations, International competition (Commerce), International competition (Economics), Corporations, European

---

Dynamic and risk measurement perspectives on Bowman's risk-return paradox for strategic management: an empirical study

Article Abstract:

The risk-return paradox in strategic management is analyzed over a period of time for different companies and industries, using both market-based and accounting-based measurement techniques. The paradox is seen to vary according to the time period used, suggesting the operation of prevalent economic conditions. Results also vary according to the measurement technique used: market-based technique is useful from the financial market perspective, and accounting-based or total risk technique is valuable for strategic planning.

Methods, Management, Risk assessment, Return on investment, Rate of return

---

The impact of diversification strategy on risk-return performance

Article Abstract:

The effects of a diversification strategy on return and risks in a diversified company are examined using regression analysis. The analysis shows that: the diversification strategy chosen has less influence on risk and return performance than business and market structural patterns; diversification strategy choice is influenced by returns; and a curvilinear risk-return relationship exists.

Similar abstracts:

• Abstracts: A longitudinal study of the cause and consequences of changes in diversification in the U.S. pharmaceutical industry 1977-1986
• Abstracts: Assessing generic strategies: an empirical investigation of two competing typologies in discrete manufacturing industries

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.